Robert Latek

9.5k citations
35 papers · 7.9k · 5 hit papers · h-index 17

Impact in

  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research
    • PI3K/AKT/mTOR signaling in cancer
    • Protein Kinase Regulation and GTPase Signaling
    • Polyamine Metabolism and Applications
    • Metabolism, Diabetes, and Cancer

Papers in

    • Ubiquitin and proteasome pathways 3
    • Protein Kinase Regulation and GTPase Signaling 3
    • Cancer Immunotherapy and Biomarkers 11
    • CAR-T cell therapy research 3

Robert Latek

32 papers receiving 7.8k citations

Robert Latek's Hit Papers

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 2017 · 376 citations
3760+8+16Years since publication50010001.5k2.0k2.5k

Peers

Robert Latek
Comparison fields: 5 of 118
  • Genetics 836
  • Molecular Biology 5.4k
  • Aging 138
  • Immunology 1.1k
  • Cell Biology 803
Replace Estela Jacinto with:
Estela Jacinto United States
Diane C. Fingar United States
Christian Rommel United States
Shomit Sengupta United States
Joseph T. Opferman United States
Noriko Oshiro Japan
Stefano Fumagalli France
Timothy R. Peterson United States
Andrew R. Tee United Kingdom
Tim M. Townes United States
Robert Latek relative to Estela Jacinto United States Estela Jacinto's profile →
Citations per field
00.5×1.5×2.2×
Estela Jacinto · 1×
Citations per year

Countries citing papers authored by Robert Latek

Since Specialization
Citations

This map shows the geographic impact of Robert Latek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Latek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Latek more than expected).

Fields of papers citing papers by Robert Latek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Latek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Latek. The network helps show where Robert Latek may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Latek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Latek Line = papers co-authored together Robert Latek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
Hit paper breakdown →
20022509
2
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Hit paper breakdown →
20042232
3
GβL, a Positive Regulator of the Rapamycin-Sensitive Pathway Required for the Nutrient-Sensitive Interaction between Raptor and mTOR
Hit paper breakdown →
2003825
4
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL
Hit paper breakdown →
2003515
5
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Hit paper breakdown →
2017376
6 2004319
7 2004264
8 2003214
9 2000171
10 1995111
11 200391
12 200985
13 201645
14 199939
15 201635
16 200020
17 201817
18 201416
19 201812
20 20237

About Robert Latek

Robert Latek is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers), Ubiquitin and proteasome pathways (3 papers), Renal Transplantation Outcomes and Treatments (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), CAR-T cell therapy research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Genetics (836 citations), Molecular Biology (5.4k citations), Aging (138 citations), Immunology (1.1k citations) and Cell Biology (803 citations). Robert Latek has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Hediye Erdjument‐Bromage, David M. Sabatini, Do‐Hyung Kim, Siraj M. Ali, Paul Tempst, Dos D. Sarbassov, Jessie E. King, David A. Guertin, Mohammad Azam and George Q. Daley. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Transplantation, Cell and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact